U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 93

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr8:43024386-43028855
HGSNATSanfilippo syndromeLikely pathogenic
(Jan 25, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr12:65122781
GRCh38:
Chr12:64729001
GNSD385EMucopolysaccharidosis, MPS-III-DLikely benign
(Oct 19, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr12:65137090
GRCh38:
Chr12:64743310
GNSMucopolysaccharidosis, MPS-III-DLikely pathogenic
(Jun 27, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr12:65137015
GRCh38:
Chr12:64743235
GNSA233VMucopolysaccharidosis, MPS-III-DUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr12:65137037
GRCh38:
Chr12:64743257
GNSF226VMucopolysaccharidosis, MPS-III-DUncertain significance
(Mar 26, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr12:65152897
GRCh38:
Chr12:64759117
GNST54AMucopolysaccharidosis, MPS-III-DUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr12:65122789
GRCh38:
Chr12:64729009
GNSG383SMucopolysaccharidosis, MPS-III-DUncertain significance
(Jan 14, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr12:65110562
GRCh38:
Chr12:64716782
GNSG540SMucopolysaccharidosis, MPS-III-DUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr8:43048899
GRCh38:
Chr8:43193756
HGSNATSanfilippo syndromePathogenic
(Feb 7, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr12:65139502
GRCh38:
Chr12:64745722
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Sep 7, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr12:65134411
GRCh38:
Chr12:64740631
GNSF284LMucopolysaccharidosis, MPS-III-DUncertain significance
(May 29, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr12:65115494
GRCh38:
Chr12:64721714
GNSSanfilippo syndromeUncertain significance
(Aug 17, 2020)
no assertion criteria provided
13.
GRCh37:
Chr12:65110517-65110518
GRCh38:
Chr12:64716737-64716738
GNSMucopolysaccharidosis, MPS-III-DUncertain significance
(Feb 26, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr12:65133282
GRCh38:
Chr12:64739502
GNSMucopolysaccharidosis, MPS-III-DUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr12:65152940
GRCh38:
Chr12:64759160
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Nov 1, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr8:43047462-43047463
GRCh38:
Chr8:43192319-43192320
HGSNATI361fs, I137fs, I425fsRetinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C, Sanfilippo syndrome
Pathogenic
(Sep 22, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr12:65153052
GRCh38:
Chr12:64759272
GNSR2PInborn genetic diseases, Mucopolysaccharidosis, MPS-III-DUncertain significance
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr12:65133187
GRCh38:
Chr12:64739407
GNSY323CMucopolysaccharidosis, MPS-III-DUncertain significance
(Jul 3, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr12:65116784
GRCh38:
Chr12:64723004
GNSMucopolysaccharidosis, MPS-III-DLikely pathogenic
(Oct 29, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr12:65136922
GRCh38:
Chr12:64743142
GNST264MMucopolysaccharidosis, MPS-III-DUncertain significance
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr12:65130856
GRCh38:
Chr12:64737076
GNSMucopolysaccharidosis, MPS-III-DBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr12:65122823
GRCh38:
Chr12:64729043
GNSMucopolysaccharidosis, MPS-III-DBenign
(Nov 1, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr12:65113930
GRCh38:
Chr12:64720150
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Jun 4, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr12:65113804
GRCh38:
Chr12:64720024
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Jul 12, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr12:65152925
GRCh38:
Chr12:64759145
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Mar 23, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr12:65153027
GRCh38:
Chr12:64759247
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Oct 7, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr12:65139496
GRCh38:
Chr12:64745716
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Oct 25, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr12:65134477
GRCh38:
Chr12:64740697
GNSMucopolysaccharidosis, MPS-III-DLikely benign
(Sep 29, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr12:65138636
GRCh38:
Chr12:64744856
GNSR193WMucopolysaccharidosis, MPS-III-DConflicting interpretations of pathogenicity
(Nov 2, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr12:65137031
GRCh38:
Chr12:64743251
GNSM228VMucopolysaccharidosis, MPS-III-DUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr12:65137025
GRCh38:
Chr12:64743245
GNSA230TMucopolysaccharidosis, MPS-III-DUncertain significance
(Mar 26, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr8:43024359
GRCh38:
Chr8:43169216
HGSNATR203*Mucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Sanfilippo syndrome
Pathogenic
(Aug 2, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr8:43052991
GRCh38:
Chr8:43197848
HGSNATS541L, S477L, S253L, S570LRetinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C, Mucopolysaccharidosis, MPS-III-C,
Sanfilippo syndrome, Retinal dystrophy
Pathogenic/Likely pathogenic
(Jul 28, 2023)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr8:43047466
GRCh38:
Chr8:43192323
HGSNATG424S, G360S, G136SMucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C,
Sanfilippo syndrome
Conflicting interpretations of pathogenicity
(Sep 22, 2022)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr8:43033312
GRCh38:
Chr8:43178169
HGSNATW316*, W28*Mucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C,
Sanfilippo syndrome
Pathogenic/Likely pathogenic
(Oct 23, 2021)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr8:43052142
GRCh38:
Chr8:43196999
HGSNATR506*, R218*, R535*, R442*not provided, Mucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73,
Mucopolysaccharidosis, MPS-III-C, Sanfilippo syndrome
Pathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr8:43046638
GRCh38:
Chr8:43191495
HGSNATR384*, R96*, R320*not provided, Retinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C,
Sanfilippo syndrome, Mucopolysaccharidosis, MPS-III-C
Pathogenic
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr12:65141708
GRCh38:
Chr12:64747928
GNSMucopolysaccharidosis, MPS-III-D, not specifiedBenign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr17:40695621
GRCh38:
Chr17:42543603
NAGLUR533*Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Sanfilippo syndrome,
not provided, Inborn genetic diseases, Mucopolysaccharidosis, MPS-III-B
Pathogenic/Likely pathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr12:65116832
GRCh38:
Chr12:64723052
GNSR421HMucopolysaccharidosis, MPS-III-D, not providedUncertain significance
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr8:43025833
GRCh38:
Chr8:43170690
HGSNATR247fsRetinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C, not provided,
Sanfilippo syndrome, Mucopolysaccharidosis, MPS-III-C
Pathogenic
(Feb 13, 2023)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr12:65152980
GRCh38:
Chr12:64759200
GNSL26Pnot provided, Inborn genetic diseasesUncertain significance
(Mar 20, 2023)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr8:43047463
GRCh38:
Chr8:43192320
HGSNATG423W, G359W, G135WMucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Sanfilippo syndrome,
not provided, Retinal dystrophy, Mucopolysaccharidosis, MPS-III-C
Conflicting interpretations of pathogenicity
(Aug 30, 2023)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr17:78187651
GRCh38:
Chr17:80213852
SGSHR233*not provided, Sanfilippo syndrome, Mucopolysaccharidosis, MPS-III-A
Pathogenic/Likely pathogenic
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr8:43057747-43057748
GRCh38:
Chr8:43202604-43202605
HGSNATSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
46.
GRCh37:
Chr8:43055809-43055812
GRCh38:
Chr8:43200666-43200669
HGSNATSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
47.
GRCh37:
Chr8:43046725
GRCh38:
Chr8:43191582
HGSNATP413S, P349S, P125SInborn genetic diseases, Retinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C,
Retinitis pigmentosa 73, not specified, Sanfilippo syndrome,
Mucopolysaccharidosis, MPS-III-C
Conflicting interpretations of pathogenicity
(Nov 15, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr8:42995603
GRCh38:
Chr8:43140460
HGSNAT, LOC130000316Sanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
49.
GRCh37:
Chr17:78194135
GRCh38:
Chr17:80220336
LOC130061900, SGSHSanfilippo syndrome, Mucopolysaccharidosis, MPS-III-AUncertain significance
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:78191006-78191009
GRCh38:
Chr17:80217207-80217210
SGSHMucopolysaccharidosis, MPS-III-A, Sanfilippo syndromeConflicting interpretations of pathogenicity
(Dec 25, 2021)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr17:78184432
GRCh38:
Chr17:80210633
SGSHR443QInborn genetic diseases, Sanfilippo syndrome, Mucopolysaccharidosis, MPS-III-A
Conflicting interpretations of pathogenicity
(Dec 28, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr17:40696451
GRCh38:
Chr17:42544433
NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
53.
GRCh37:
Chr17:40688213
GRCh38:
Chr17:42536195
LOC130060903, NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
54.
GRCh37:
Chr17:40688210
GRCh38:
Chr17:42536192
LOC130060903, NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
55.
GRCh37:
Chr17:40688209
GRCh38:
Chr17:42536191
LOC130060903, NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
56.
GRCh37:
Chr17:40688153
GRCh38:
Chr17:42536135
NAGLUnot provided, Sanfilippo syndromeBenign/Likely benign
(Apr 20, 2019)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr17:40688147
GRCh38:
Chr17:42536129
NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
58.
GRCh37:
Chr17:40688124
GRCh38:
Chr17:42536106
NAGLUnot provided, Sanfilippo syndromeConflicting interpretations of pathogenicity
(Oct 1, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr17:40688091
GRCh38:
Chr17:42536073
NAGLUSanfilippo syndrome, not providedLikely benign
(Jun 29, 2019)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr17:40688079
GRCh38:
Chr17:42536061
NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
61.
GRCh37:
Chr17:40688063
GRCh38:
Chr17:42536045
NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
62.
GRCh37:
Chr17:40688020
GRCh38:
Chr17:42536002
LOC130060902, NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
63.
GRCh37:
Chr17:40688016
GRCh38:
Chr17:42535998
LOC130060902, NAGLUSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
64.
GRCh37:
Chr12:65153223-65153224
GRCh38:
Chr12:64759443-64759444
GNSSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
65.
GRCh37:
Chr12:65153217
GRCh38:
Chr12:64759437
GNSSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
66.
GRCh37:
Chr12:65153080-65153081
GRCh38:
Chr12:64759300-64759301
GNSSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
67.
GRCh37:
Chr12:65141666
GRCh38:
Chr12:64747886
GNSMucopolysaccharidosis, MPS-III-DConflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr12:65138579
GRCh38:
Chr12:64744799
GNSMucopolysaccharidosis, MPS-III-DConflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr12:65110530
GRCh38:
Chr12:64716750
GNSMucopolysaccharidosis, MPS-III-D, not providedBenign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr12:65110202
GRCh38:
Chr12:64716422
GNSSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
71.
GRCh37:
Chr12:65108660
GRCh38:
Chr12:64714880
GNSSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
72.
GRCh37:
Chr12:65107909-65107910
GRCh38:
Chr12:64714129-64714130
GNSSanfilippo syndromeLikely benign
(Jun 14, 2016)
criteria provided, single submitter
73.
GRCh37:
Chr12:65107734
GRCh38:
Chr12:64713954
GNSSanfilippo syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
74.
GRCh37:
Chr12:65107451-65107452
GRCh38:
Chr12:64713671-64713672
GNSSanfilippo syndromeLikely benign
(Jun 14, 2016)
criteria provided, single submitter
75.
GRCh37:
Chr12:65153036
GRCh38:
Chr12:64759256
GNSnot specified, Mucopolysaccharidosis, MPS-III-DBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:78184625
GRCh38:
Chr17:80210826
SGSHV379fsMucopolysaccharidosis, MPS-III-A, not provided, Sanfilippo syndrome
Pathogenic
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr8:43048933
GRCh38:
Chr8:43193790
HGSNATE471K, E183K, E407KSanfilippo syndrome, Retinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C,
not provided
Pathogenic
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr12:65110582
GRCh38:
Chr12:64716802
GNSR533Hnot provided, not specified, Mucopolysaccharidosis, MPS-III-D
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr17:78184732-78184733
GRCh38:
Chr17:80210933-80210934
SGSHL343fsSanfilippo syndrome, not provided, Inborn genetic diseases,
Mucopolysaccharidosis, MPS-III-A
Pathogenic/Likely pathogenic
(Feb 14, 2023)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr12:65153053
GRCh38:
Chr12:64759273
GNSR2Wnot specified, not provided, Mucopolysaccharidosis, MPS-III-D
Conflicting interpretations of pathogenicity
(Oct 30, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr8:43046739
GRCh38:
Chr8:43191596
HGSNATSanfilippo syndrome, Mucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73,
Retinitis pigmentosa 73, Retinal dystrophy, not provided,
Mucopolysaccharidosis, MPS-III-C
Pathogenic/Likely pathogenic
(Oct 9, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr12:65141588
GRCh38:
Chr12:64747808
GNSnot specified, Mucopolysaccharidosis, MPS-III-DBenign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr12:65146532
GRCh38:
Chr12:64752752
GNSnot specified, not provided, Mucopolysaccharidosis, MPS-III-D
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr8:43002207
GRCh38:
Chr8:43147064
HGSNATMucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Retinal dystrophy,
Sanfilippo syndrome, not provided, Mucopolysaccharidosis, MPS-III-C
Pathogenic
(Jan 17, 2023)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr17:40695718
GRCh38:
Chr17:42543700
NAGLUR565QCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B, Sanfilippo syndrome,
not provided
Pathogenic
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr17:78185927
GRCh38:
Chr17:80212128
SGSHS298PSanfilippo syndrome, not provided, Mucopolysaccharidosis, MPS-III-A
Pathogenic
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr17:78190883
GRCh38:
Chr17:80217084
SGSHS66WSanfilippo syndrome, Inborn genetic diseases, not provided,
Mucopolysaccharidosis, MPS-III-A
Pathogenic
(Sep 1, 2023)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr17:78187614
GRCh38:
Chr17:80213815
CARD14, SGSHR245HSGSH-related condition, Inborn genetic diseases, Sanfilippo syndrome,
not provided, Mucopolysaccharidosis, MPS-III-A
Pathogenic
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr8:43037305
GRCh38:
Chr8:43182162
HGSNATR344C, R280C, R56CSanfilippo syndrome, Mucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73,
not provided, Mucopolysaccharidosis, MPS-III-C
Pathogenic/Likely pathogenic
(Jan 23, 2023)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr8:43014064
GRCh38:
Chr8:43158921
HGSNATRetinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C, Sanfilippo syndrome
Pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr8:43048967
GRCh38:
Chr8:43193824
HGSNATM482K, M418K, M194KMucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Sanfilippo syndrome
Likely pathogenic
(Jul 12, 2023)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr8:43028883
GRCh38:
Chr8:43173740
HGSNATP283LMucopolysaccharidosis, MPS-III-C, Retinitis pigmentosa 73, Sanfilippo syndrome,
not provided
Pathogenic/Likely pathogenic
(Aug 18, 2023)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr8:43014188
GRCh38:
Chr8:43159045
HGSNATInborn genetic diseases, Retinitis pigmentosa 73, Mucopolysaccharidosis, MPS-III-C,
Sanfilippo syndrome, Mucopolysaccharidosis, MPS-III-C
Pathogenic
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination